검색어 : 통합검색[Hilpert Ulrich]
총 45건 중 45건 출력
, 4/5 페이지
-
31
- Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer
- Stockler, Martin R.; Hilpert, Felix; Friedlander, Michael; King, Madeleine T.; Wenzel, Lari; Lee, Chee Khoon; Joly, Florence; de Gregorio, Nikolaus; Arranz, José Angel; Mirza, Mansoor Raza; Sorio, Roberto; Freudensprung, Ulrich; Sneller, Vesna; Hales, Gill; Pujade-Lauraine, Eric; Martin R. Stockler, Madeleine T. King, Chee Khoon Lee, The University of Sydney; Michael Friedlander, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia; Felix Hilpert, Arbeitsgemeinschaft Gynä kologische Onkologie (AGO) and Klinik fü r Gynä kologie und Geburtshilfe, Kiel; Nikolaus de Gregorio, AGO and University of Ulm Medical Center, Ulm, Germany; Lari Wenzel, University of California Irvine, Irvine, CA; Florence Joly, Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Franç ois Baclesse, Caen; Eric Pujade-Lauraine, GINECO and Centre Hospitalier Universitaire Hotel Dieu, Paris, France; José Angel Arranz, Grupo Españ ol de Investigació n en Cá ncer de Ovario and Hospital General Universitario Gregorio Marañ ó n, Madrid, Spain; Mansoor Raza Mirza, Nordic Society of Gynaecological Oncology and Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Rober; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.32, 2014, pp.1309-1316)
-
32
- Erfassung von Standardgeometrieelementen im Mikrometerbereich: Herausforderungen und Lösungsansätze (Characterization of Standard-Geometry Micro Structures: Chances and Challenges)
- Fleischer, Jü rgen; Buchholz, Ivesa; Peters, Jochen; Viering, Benjamin; Goch, Gert; Patzelt, Stefan; Tausendfreund, Andreas; Mehner, Jan; Dö tzel, Wolfram; Shaporin, Alexey; Neuschaefer-Rube, Ulrich; Hilpert, Uwe; Simon, Sven; Tutsch, Rainer; Herbst, Christian; Weckenmann, Albert; Hoffmann, Jö rg; Krä mer, Philipp; ; (Technisches messen : TM, v.75, 2008, pp.327-338)
-
33
- Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7
- Heublein, Sabine; Pfisterer, Jacobus; du Bois, Andreas; Anglesio, Michael; Aminossadati, Behnaz; Bhatti, Irfan; Sehouli, Jalid; Wimberger, Pauline; Schochter, Fabienne; Hilpert, Felix; Hillemanns, Peter; Kalder, Matthias; Schroeder, Willibald; Mahner, Sven; Burges, Alexander; Canzler, Ulrich; Gropp-Meier, Martina; Jackisch, Christian; Harter, Philipp; Kommoss, Stefan; Marmé , Frederik; ; (Laboratory investigation, v.104, 2024, pp.100321)
-
34
- Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabin plus carboplatin (GC) or carboplatin plus pegylated doxorubicin (PLDC): A randomized phase III trial of the NOGGO-AGO-Germany-AGO Austria and GEICO-GCIG intergroup study (HECTOR).
- Sehouli, Jalid; Meier, Werner; Wimberger, Pauline; Chekerov, Radoslav; Belau, Antje; Mahner, Sven; Kurzeder, Christian; Hilpert, Felix; Klare, Peter; Doerfel, Steffen; Strauss, Hans-Georg; Canzler, Ulrich; Marth, Christian; Reinthaller, Alexander; Petru, Edgar; Richter, Rolf; Rubio, Maria Jesus; Bover, Isabel; Gonzalez-Martin, Antonio; Harter, Philipp; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Campus Virchow Klinikum, Berlin, Germany; Evangelical Hospital, Dü sseldorf, Germany; AGO and Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany; Charité University Department of Gynecology, Campus Virchow Clinic, Berlin, Germany; Ernst Moritz Arndt Universitä t Greifswald - Klinik und Poliklinik fü r Frauenheilkunde und Geburtshilfe, Greifswald, Germany; University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany; Universitaetsfrauenklinik ULM, Ulm, Germany; University Medical Center Kiel, Department for Obstetrics and Gynecology, Kiel, Germany; Praxisklinik Krebsheilkunde, Berlin, Germany; Onkozentrum Dresden, Dresden, Germany; Universitä tsklinikum Halle, Halle, Germany; University of Dresden Deptartment of Gynecology and Obstetrics, Dresden, Germany; Medical University of Innsbruck, Innsbruck, Austr; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.30, 2012, pp.5031-5031)
-
35
- LION-PAW: Lymphadenectomy in ovarian neoplasm-pleasure ability of women-Prospective substudy of the randomized multicenter LION study.
- Hasenburg, Annette; Sehouli, Jalid; Lampe, Boern; Reuss, Alexander; Schmalfeldt, Barbara; Belau, Antje Kristina; Bossart, Michaela; Mahner, Sven; Hillemanns, Peter; Petry, Karl-Ulrich; Du Bois, Andreas; Herwig, Uwe; Hilpert, Felix; Gropp-Meier, Martina; Hanf, Volker; Janni, Wolfgang; Greimel, Elfriede; Wagner, Uwe A. G.; Harter, Philipp; University of Mainz, Mainz, Germany; ; AGO and Charité Campus Virchow-Klinikum, Berlin, Germany; ; AGO and Kaiserswerther Diakonie, Duesseldorf, Germany; ; AGO and Coordinating Center for Clinical Trials, Marburg, Germany; ; Department of Gynecology and Obstetrics, Klinikum rechts der Isar, Muenchen, Germany, Muenchen, Germany; ; Ernst Moritz Arndt Universitä t Greifswald - Klinik und Poliklinik fü r Frauenheilkunde und Geburtshilfe, Greifswald, Germany; ; Universtiy Medical Center Freiburg, Freiburg, DE; ; Ludwig-Maximilians-Universitä t Mü nchen and University Medical Center Hamburg-Eppendorf, Germany, Munich, Germany; ; Hannover Medical School, Department of Obstetrics and Gynecology, Breast Center, Hannover, Germany; ; Klinikum Wolfsburg, Wolfsburg, Germany; ; AGO Study Group & Kliniken Essen Mitte, Essen, Germany; ; Albertinen-Krankenhaus, Hamburg, Germany; ; Onkologisches Therapiezentrum am Krankenhaus Jerusalem, Hamburg, Germany; ; Oberschwabenklinik, Rave; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.36, 2018, pp.5575-5575)
-
36
- Prediction of post-operative residual disease in advanced-stage ovarian cancer (AOC) using whole transcriptome expression: An exploratory analysis of the AGO-OVAR 11 (ICON7) trial.
- Heitz, Florian; Kommoss, Stefan; Winterhoff, Boris J. N.; Aliferis, Constantin; Burges, Alexander; Wang, Chen; Canzler, Ulrich; Wang, Jinhua; Belau, Antje Kristina; Hanker, Lars Christian; Ma, Sisi; Hilpert, Felix; Sehouli, Jalid; Tourani, Roshan; Kimmig, Rainer; Kurzeder, Christian; Schmalfeldt, Barbara; Dowdy, Sean Christopher; Du Bois, Andreas; Pfisterer, Jacobus; Department of Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; ; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany; ; Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN; ; Institute for Health Informatics (IHI), Academic Health Center, University of Minnesota, Minneapolis, MN; ; AGO and Department of Gynecology, University Hospital Munich-Großhadern, Munich, Germany; ; Mayo Clinic, Rochester, MN; ; Department of Gynecology and Obstetrics, University of Dresden, Dresden, Germany; ; Institute for Health Informatics (IHI), Academic Health Center, University of Minnesota, Minneapolis, MN; ; Ernst Moritz Arndt Universitä t Greifswald - Klinik und Poliklinik fü r Frauenheilkunde und Geburtshilfe, Greifswald, Germany; ; University of Schleswig-Holstein, Lü beck, Germany; ; Institute for Health Informatics (IHI), Academic Health Center, University of Minnesota, Minneapolis, MN; ; Arbeitsgemeinschaft Gynä kologis; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.36, 2018, pp.5550-5550)
-
37
- PENELOPE/AGO-OVAR 2.20: A double-blind placebo (PLA)-controlled randomized phase III ENGOT trial evaluating chemotherapy (CT) with or without pertuzumab (P) for platinum-resistant ovarian cancer.
- Kurzeder, Christian; Del Campo, Jose Maria; Pautier, Patricia; Hilpert, Felix; Gadducci, Angiolo; Ottevanger, Petronella; Lorusso, Domenica; Vergote, Ignace; Bover, Isabel; Fabbro, Michel; Marmé , Frederik; Garcia, Yolanda; Selle, Fré dé ric; Gropp-Meier, Martina; Pardo, Beatriz; Freudensprung, Ulrich; Walker, Ru-Amir; Gonzalez-Martin, Antonio; Kliniken Essen Mitte, Essen, Germany; GEICO and Vall d'Hebron University Hospital, Barcelona, Spain; Department of Medicine, Gustave Roussy, Villejuif, France; Department of Obstetrics and Gynecology, University of Schleswig-Holstein, Kiel, Germany; MaNGO and Division of Gynecology and Obstetrics, Department of Procreative Medicine, University of Pisa, Pisa, Italy; DGOG and Department of Medical Oncology, St. Radboud University Nijmegen Medical Center, Nijmegen, Netherlands; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; AGO and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium; GEICO and Son Llatzer University Hospital, Mallorca, Spain; GINECO and CRLC Val d'Aurelle, Mé decine B2, Montpellier, France; AGO and University Hospital Heidelberg, Heidelberg, Germany; GEICO and Hospital Parc Tauli-IOV, Barcelona, Spain; GINECO and Hô pital Tenon, Paris, France; AGO and Frauenklinik St. Elisabeth, Ravensburg, Germany; GEICO and IDIBELL,; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.32, 2014, pp.TPS5613-TPS5613)
-
38
- Outcome of patients with borderline ovarian tumors: Results of the multicenter AGO ROBOT study.
- De Gregorio, Nikolaus; Baumann, Klaus H.; Keyver-Paik, Mignon-Denise; Reuss, Alexander; Canzler, Ulrich; Wollschlaeger, Kerstin; Kommoss, Friedrich; Forner, Dirk; Peters, Martin; Schroeder, Willibald; Mü nstedt, Karsten; Richter, Barbara; Ewald-Riegler, Nina; Mahner, Sven; Fotopoulou, Christina; Schmalfeldt, Barbara; Hilpert, Felix; Kommoss, Stefan; Hauptmann, Steffen; Du Bois, Andreas; University of Ulm Medical Center, Ulm, Germany; Philipps University Marburg, Marburg, Germany; Department of Obstetrics and Gynecology, University Hospital Bonn, Bonn, Germany; AGO and Coordinating Center for Clinical Trials, Marburg, Germany; University of Dresden Department of Gynecology and Obstetrics, Dresden, Germany; University Medical Center Magdeburg, Department of Obstetrics and Gynecology, Magdeburg, Germany; Institute of Pathology, Referral Centre for Gynecopathology, Mannheim, Germany; Sana-Klinikum Remscheid, Department of Gynecology, Remscheid, Germany; Stä dtisches Klinikum Solingen, Department of Gynecology, Solingen, Germany; Gynecologicum Bremen, Bremen, Germany; University Hospital Giesen, Gießen, Germany; Elblandklinikum Radebeul, Radebeul, Germany; HSK, Dr. Horst Schmidt Klinik, Wiesbaden, Germany; University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany; European Competence Centre for Ovarian Cancer, Charite-Unive; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.30, 2012, pp.5005-5005)
-
39
- Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study
- Klapdor, Rü diger; Wö lber, Linn; Hanker, Lars; Schmalfeldt, Barbara; Canzler, Ulrich; Fehm, Tanja; Luyten, Alexander; Hellriegel, Martin; Kosse, Jens; Heiss, Christoph; Hantschmann, Peer; Mallmann, Peter; Tanner, Berno; Pfisterer, Jacobus; Jü ckstock, Julia; Hilpert, Felix; de Gregorio, Nikolaus; Hillemanns, Peter; Fü rst, Sophie Teresa; Mahner, Sven; Department of Gynecology, Hannover Medical School; Department of Gynecology, University Medical Center Hamburg-Eppendorf; Department of Gynecology; Department of Gynecology, University Medical Center Hamburg-Eppendorf; Department of Gynecology and Obstetrics, Carl-Gustav-Carus University Dresden; Department of Gynecology, Duesseldorf University Hospital; Department of Obstetrics and Gynecology, Klinikum Wolfsburg; Department of Gynecology and Obstetrics, Georg-August-University; Department of Gynaecology, Sana Klinikum Offenbach; Department of Gynecology, Alb Fils Kliniken; Department of Gynecology, Hospital Altoettingen, Altoettignen; Department of Gynecology, University Hospital Co; (Gynecologic oncology, v.154, 2019, pp.565-570)
-
40
- Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer
- Heitz, Florian; Kommoss, Stefan; Tourani, Roshan; Grandelis, Anthony; Uppendahl, Locke; Aliferis, Constantin; Burges, Alexander; Wang, Chen; Canzler, Ulrich; Wang, Jinhua; Belau, Antje; Prader, Sonia; Hanker, Lars; Ma, Sisi; Ataseven, Beyhan; Hilpert, Felix; Schneider, Stephanie; Sehouli, Jalid; Kimmig, Rainer; Kurzeder, Christian; Schmalfeldt, Barbara; Braicu, Elena I.; Harter, Philipp; Dowdy, Sean C.; Winterhoff, Boris J.; Pfisterer, Jacobus; du Bois, Andreas; Department of Gynecology and Gynecologic Oncology, Kliniken-Essen-Mitte, Germany.; AGO Study Group.; Institute for Health Informatics (IHI), Academic Health Center, University of Minnesota, Minneapolis, Minnesota.; Department of Gynecology, Obstetrics and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota.; Department of Gynecology, Obstetrics and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota.; Institute for Health Informatics (IHI), Academic Health Center, University of Minnesota, Minneapolis, Minnesota.; AGO Study Group.; Division of Gynecologic Surgery, Department of Obstetrics and Gynecology; Mayo Clinic, Rochester, Minnesota.; AGO Study Group.; Institute for Health Informatics (IHI), Academic Health Center, University of Minnesota, Minneapolis, Minnesota.; AGO Study Group.; Department of Gynecology and Gynecologic Oncology, Kliniken-Essen-Mitte, Germany.; AGO Study Group.; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.26, 2020, pp.213-219)
QUICK MENU
